Amyloid-targeting imaging agents such as radiolabeled amyloid targeting molecules and amyloid targeting molecule-chelator conjugates for imaging, e.g., amyloid plaques <i>in vivo</i>, and/or for the treatment of amyloidosis disorders. The invention provides amyloid-targeting imaging agents that are useful for imaging sites of amyloid disease. Imaging agents of the invention are capable of binding specifically to amyloid plaques, as an aid in diagnosis and/or early treatment of amyloidosis disorders.
申请公布号
WO0207781(A2)
申请公布日期
2002.01.31
申请号
WO2001CA01071
申请日期
2001.07.25
申请人
NEUROCHEM INC.;GERVAIS, FRANCINE;KONG, XIANQI;CHALIFOUR, ROBERT;MIGNEAULT, DAVID
发明人
GERVAIS, FRANCINE;KONG, XIANQI;CHALIFOUR, ROBERT;MIGNEAULT, DAVID